CRWV Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
CoreWeave is not a clear buy right now for a Beginner, long-term investor with $50,000-$100,000 to deploy. The business is growing very fast and Wall Street is broadly constructive, but the stock just reacted to a mixed Q1 report with a sharp drop, and the setup is better for traders than for an impatient long-term buyer. My direct view: wait rather than buy now.
The trend is still constructive on the chart, but momentum is cooling. SMA_5 is above SMA_20 and SMA_200, which is bullish, and MACD remains above zero. However, the MACD histogram is positively contracting, RSI_6 at 61 is only moderately bullish, and the stock closed sharply lower at 116.92 after trading at 128.84 previously. Key levels: pivot 120.19, resistance 133.64, support 106.74. The current price is below the pivot after a weak session, so near-term price action is not confirming a fresh entry.
Recent analyst action is strongly positive, with multiple firms raising price targets and reiterating Buy/Outperform views. Big catalysts include strong AI infrastructure demand, major contract wins such as Jane Street, Meta, and Anthropic, and expectations for backlog/RPO growth from new deals. Q1 revenue growth was extremely strong year over year, showing that demand remains intense. The company also continues to expand capacity, which is the core growth driver.
The latest Q1 report was mixed: revenue beat expectations, but losses widened significantly and adjusted EPS missed. Rising expenses and debt financing are pressuring profitability. The stock sold off hard after the report, showing the market is sensitive to margin and cash-flow concerns. There is also no supportive insider, hedge fund, or congressional trading signal. Recent options volume leaned cautious, and the short-term pattern suggests possible weakness over the next week.
Latest quarter shown: 2025/Q4, with revenue up 110.31% YoY to 1.57 billion, but net income remained negative at -452.0 million and EPS was -1.04. Gross margin fell to 67.61%, down 10.60 points YoY, which is the main concern. For the latest reported season, 2026/Q1, revenue jumped 111.6% to about $2.08 billion and another figure cites $2.23 billion, but losses widened to roughly $740 million and adjusted loss per share was -$1.12. The trend is strong top-line growth, but profitability is still deteriorating.
Wall Street is broadly bullish. BofA, Jefferies, Citi, Oppenheimer, Cantor Fitzgerald, Wolfe Research, and Evercore all have Buy/Outperform/Overweight-type views with target raises into the $140-$160 range. The main bull case is accelerating AI compute demand, major backlog growth, and capacity expansion. The lone notable bear view is Bernstein with an Underperform and a much lower target, focused on longer-term issues. Overall, pros are bullish on growth and demand; cons focus on margin pressure, financing needs, and eventual scalability risks.
